Sphingosine-1-phosphate receptors respond differently to early myocardial ischemia and ischemia-reperfusion in vivo.
- Author:
Geng-Qian ZHANG
1
;
Zheng LIANG
;
Xiao-Jia ZHANG
Author Information
1. School of Forensic Medicine, Shanxi Medical University, Taiyuan 030001, China. zgengqian@163.com.
- Publication Type:Journal Article
- MeSH:
Animals;
Lysophospholipids;
physiology;
Myocardial Reperfusion Injury;
physiopathology;
Rats;
Receptors, Lysosphingolipid;
physiology;
Sphingosine;
analogs & derivatives;
physiology
- From:
Acta Physiologica Sinica
2014;66(2):169-174
- CountryChina
- Language:English
-
Abstract:
Sphingosine-1-phosphate (S1P) has been demonstrated to be a mediator and marker of heart diseases. We hypothesized that the expression of S1P receptors is involved in the S1P-mediated cardioprotection in vivo and may serve as a biomarker of ischemic heart disease. In vivo models of myocardial ischemia (MI) and ischemia-reperfusion (IR) were established by ligation of the left anterior descending artery (LAD) of rat heart, the mRNA expressions of S1PR1-3 were detected using real time PCR at different time intervals after ischemia (LAD for 15 min, 30 min, and 1 h) and IR. The results showed that mRNA expression of S1PR3, but not S1PR1 and S1PR2, increased greatly after IR. No statistical difference was found in any of the three S1P receptors after MI within 1 h. Regarding the studies of lipid concentration changes in myocardiopathy, we conclude that S1P receptors are not early response biomarkers for MI. There are different mechanisms when S1P plays a protection role in heart during MI and IR. The cooperation of lipid content and S1P receptor expression appears to form a regulation network during MI and IR.
